The Molecular Biology Society of Japan

[3P-0427] New combination therapy of HCC by CDK4/6 inhibitor in combination with a kinase inhibitor

○JIN DAN SHENG1, Chiaki Takahashi1, Susumu Kohno1, Nobuhiro Okada2 (1.Dept. of Oncology Mol. Cell Biol. ,CRI, 2.Grad. Sch. of interdisciplinary Sci.& EIHS)

Hepatocellular carcinoma (HCC), CDK4, CDK6, RB1

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password